Routine Sildenafil Does Not Improve Clinical Outcomes After Fontan Operation
- 7 September 2017
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 38 (8) , 1703-1708
Abstract
Fontan operation can be complicated by persistent chest tube output (CTO) leading to prolonged hospital length of stay (LOS). Postoperative sildenafil administration has been shown to improve clinical outcomes in selected patients after Fontan. We initiated a practice change utilizing intravenous (IV) sildenafil in early postoperative period in all patients undergoing Fontan operation with aim to decrease LOS and CTO. Nineteen patients (February 2014–May 2016) received 0.35 mg/kg sildenafil IV (three doses) followed by enteral, 1 mg/kg every eight hours until hospital discharge. Clinical outcomes were compared to 84 pre-protocol controls. Vital signs were recorded after second sildenafil dose. Demographics were similar between groups. Sildenafil group had longer median LOS [9 (7, 11) vs. 13 (8, 25) days, p = 0.016]. CTO days were longer [6 (5, 8) vs. 8 (6, 13) days, p = 0.011]. Sildenafil group had longer mechanical ventilation [6.9 (3.5, 11.1) vs. 4 (2, 7) h, p = 0.045] and longer oxygen therapy [99 (52, 225) vs. 14.5 (14, 56) h, p = 0.001]. There was a trend towards more albumin 5% resuscitation in first 24 h [17 (1, 30) vs. 21 (10, 40) ml/kg, p = 0.069]. There was no difference in inotrope score at 24 h, maximum lactate, or fluid balance. Readmission rates were similar. There was no mortality. IV sildenafil was well tolerated, and no doses were held. Routine early administration of sildenafil after Fontan operation is not associated with an improvement in any measured clinical outcome, including postoperative CTO, LOS, colloid administration, or duration of mechanical ventilation.Keywords
This publication has 29 references indexed in Scilit:
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial HypertensionCirculation, 2012
- Vasoactive–inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass*Pediatric Critical Care Medicine, 2010
- An empirically based tool for analyzing mortality associated with congenital heart surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Inhaled Nitric Oxide Therapy After Fontan-Type OperationsSurgery Today, 2005
- Risk factors for persistent pleural effusions after the extracardiac Fontan procedureThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Basal Pulmonary Vascular Resistance and Nitric Oxide Responsiveness Late After Fontan-Type OperationCirculation, 2003
- Univentricular repair: is routine fenestration justified?The Annals of Thoracic Surgery, 2000
- Rebound Pulmonary Hypertension After Inhalation of Nitric OxideThe Annals of Thoracic Surgery, 1996
- Fontan operation: Influence of modifications on morbidity and mortalityThe Annals of Thoracic Surgery, 1994
- Quantitative structural study of pulmonary circulation in the newborn with aortic atresia, stenosis, or coarctation.Thorax, 1977